Established murine lupus nephritis does not respond to exogenous interleukin-1 receptor antagonist; a role for the endogenous molecule?
- 31 August 1995
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 30 (2), 131-137
- https://doi.org/10.1016/0162-3109(95)00014-k
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.JCI Insight, 1994
- Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.JCI Insight, 1994
- Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonistKidney International, 1993
- Extrarenal cytokines modulate the glomerular response to IgA immune complexesKidney International, 1992
- Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.JCI Insight, 1992
- Thromboxane receptor blockade reduces renal injury in murine lupus nephritisKidney International, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Interleukin-1 and interleukin-1 antagonismBlood, 1991
- A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbitsThe FASEB Journal, 1991
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990